SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-054086
Filing Date
2021-08-31
Accepted
2021-08-31 16:36:05
Documents
2
Period of Report
2021-08-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1683
2 POA DOCUMENT poa.txt EX-24.3_1006483 3313
  Complete submission text file 0001209191-21-054086.txt   6337
Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Issuer) CIK: 0001619856 (see all company filings)

IRS No.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address
Whiting Nancy (Reporting) CIK: 0001880609 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40631 | Film No.: 211227430